DCT Planning Checklist: Your Guide To Ensuring A Successful Decentralized Or Hybrid Trial

Although the COVID-19 pandemic brought the benefits of decentralized clinical trials into the limelight, the approach was already becoming more popular in the life sciences industry. After witnessing the ability of DCTs to rescue several clinical trials that were in jeopardy as a result of participants being unwilling or unable to safely travel to clinical sites, more sponsors and CROs have taken note of how a mobile approach could benefit their trials.

Whether used exclusively or as part of a hybrid approach in conjunction with traditional trial methods at clinical sites, the patient-centric nature of DCTs can enable investigators to recruit and retain a diverse patient population more easily. However, without proper planning and attention to detail, a DCT won’t be able to meet its full spectrum of advantages.

Sponsors and CROs can utilize this checklist when aiming to achieve a successful decentralized trial or integration of a hybrid approach.